Table 3.
Demographics and Systemic Characteristics of Patients With WFS1
Age (Year) | |||||
---|---|---|---|---|---|
Clinical Manifestations | Patient Number | Percentage | Mean ± SD | Media | Range |
Major clinical manifestations | |||||
DM | 21 | 91.3% | 9.6 ± 8.0 | 8.0 | 2–32 |
OA | 23 | 100.0% | 12.4 ± 7.4 | 9.0 | 4–33 |
D | 9 | 39.1% | 10.0 ± 2.8 | 10.0 | 5–15 |
DI | 5 | 21.7% | 16.6 ± 14.1 | 13.0 | 5–41 |
Other system manifestations | |||||
Urinary tract dysfunction | 9 | 39.1% | 18.7 ± 12.9 | 16.0 | 6–41 |
Balance impairment | 3 | 13.0% | 6.7 ± 0.6 | 7.0 | 6–7 |
Olfactory decline | 2 | 8.7% | / | 33.0 | 24, 42 |
Psychiatric symptoms | 2 | 8.7% | / | 11.5 | 7, 16 |
Died | 1 | 4.3% | / | 13.0 | / |
Fecal incontinence | 1 | 4.3% | / | 16.0 | / |
Memory deterioration | 1 | 4.3% | / | 14.0 | / |
Tetralogy of Fallot | 1 | 4.3% | / | 0.5 | / |
SD, standard deviation.